Status:
UNKNOWN
ED90 of Norepinephrine and Phenylephrine Boluses Under Intensive Treatment
Lead Sponsor:
General Hospital of Ningxia Medical University
Conditions:
Adverse Effect
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The objective of this study is to investigate the ED90 of norepinephrine and phenylephrine boluses for treating postspinal anesthesia hypotension under intensive treatment during cesarean section
Detailed Description
Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of post-spinal anesthesia hypotension is as high as 62.1-89.7% if prophylacti...
Eligibility Criteria
Inclusion
- 18-45 years
- Primipara or multipara
- Singleton pregnancy ≥37 weeks
- American Society of Anesthesiologists physical status classification I to II
- Scheduled for cesarean section under spinal anesthesia
Exclusion
- Body height \< 150 cm
- Body weight \> 100 kg or body mass index (BMI) ≥ 40 kg/m2
- Eclampsia or chronic hypertension or baseline blood pressure ≥180 mmHg
- Hemoglobin \< 7g/dl
- Fetal distress, or known fetal developmental anomaly
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06158009
Start Date
April 1 2025
End Date
June 30 2025
Last Update
December 6 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.